• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Carmine Therapeutics appoints Don Haut as CEO prnasia
    May 08, 2021
    Carmine Therapeutics, Inc., an emerging leader in gene therapy, announced that Don Haut, PhD has been appointed as its Chief Executive Officer, and member of the Board of Directors.
  • Carmine, Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies americanpharmaceuticalreview
    July 09, 2020
    Carmine Therapeutics has signed a research collaboration agreement with Takeda to discover, develop and commercialize non-viral gene therapies for two rare disease targets using Carmine's REGENT technology, based on red blood cell extracellular vesicles.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service